Search results for "Opioid"

showing 10 items of 320 documents

Influence of loperamide and loperamide oxide on the anal sphincter

1992

The objective of this study was to investigate the effects of the opioid loperamide and its recently synthesized pharmacologically inactive prodrug loperamide oxide on the anal sphincter. In a double-blind, placebo-controlled crossover study, anorectal manometry was performed in 12 healthy volunteers five hours after oral bolus application of 10 mg of loperamide, loperamide oxide, or placebo. Loperamide significantly increased the threshold volumes for minimal perception and urgency to defecate (P less than 0.05) and raised the volume required to abolish recovery of the rectoanal inhibitory reflex (P less than 0.05). These findings suggest that loperamide has a specific continence-improving…

AdultMalemedicine.medical_specialtyLoperamideManometryAnal CanalPlaceboLoperamideGastroenterologyBolus (medicine)Double-Blind MethodInternal medicinePressuremedicineHumansDefecationbusiness.industryAnorectal manometryRectumGastroenterologyGeneral MedicineProdrugCrossover studyOpioidDefecationFemalebusinessmedicine.drugDiseases of the Colon & Rectum
researchProduct

Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction…

2005

Desired adjustment of methadone dose, perceived participation in dosage regulation, and satisfaction with methadone treatment centres were assessed in a sample of opioid-dependent patients from the Valencia Region (eastern Spain). An independent interviewer asked 278 consecutively arriving patients to answer the survey, and 165 (59.4%) completed it. Adjustment of methadone dose was assessed with a -10 to +10 visual analogue scale (VAS-MD); participation in methadone dose regulation, with specific questions; and patient satisfaction, with the Verona Service Satisfaction Scale for methadone treatment (VSSS-MT). The methadone dose (mg/d) prescribed by physicians was (mean+/-S.D.) 68.0+/-30.4. …

AdultMalemedicine.medical_specialtyMethadone maintenanceAdolescentVisual analogue scalemedia_common.quotation_subjectPersonal SatisfactionToxicologyDrug Administration ScheduleHeroinPatient satisfactionDose adjustmentInternal medicinemedicineHumansPharmacology (medical)Patient participationPsychiatrymedia_commonPharmacologybusiness.industryHeroin DependenceAddictionMiddle AgedOpioid-Related DisordersPsychiatry and Mental healthSpainFemaleHealth Services ResearchPatient ParticipationbusinessAttitude to HealthMethadonemedicine.drugMethadoneDrug and alcohol dependence
researchProduct

Analgesic effects of nonsteroidal anti-inflammatory drugs in cancer pain due to somatic or visceral mechanisms.

1999

The role of nonsteroidal anti-inflammatory drugs (NSAIDs) is well established in the treatment of cancer pain. This class of drugs is considered particularly effective in pain due to somatic mechanisms, although proof of this observation is lacking. To ascertain whether NSAIDs are more effective in specific nociceptive forms of cancer pain, they were administered alone or added to opioids in 32 patients with a sole pain mechanism, somatic pain due to bone metastases (17 patients) or visceral pain (15 patients), respectively. Pain intensity, mean doses of opioids used, and symptoms were recorded after starting NSAID. A significant reduction in pain intensity was found at 3, 7, and 14 days. N…

AdultMalemedicine.medical_specialtyPalliative careEpidemiologyAnalgesicPainOpioidAdverse effectPain ladderDiclofenacInternal medicineNeoplasmsMedicineHumansProspective StudiesCancer painAdverse effectNursing (all)2901 Nursing (miscellaneous)General NursingAgedAnalgesicsbusiness.industryAnti-Inflammatory Agents Non-SteroidalPalliative CareVisceral painMiddle AgedNSAIDVisceraAnesthesiology and Pain MedicineNeurologyOpioidAnesthesiaFemaleMechanismNeurology (clinical)medicine.symptombusinessCancer painmedicine.drugJournal of pain and symptom management
researchProduct

Prevalence of opioid-related dysuria in patients with advanced cancer having pain.

2010

The aim of this study was to assess the prevalence of opioid-induced dysuria in patients with advanced cancer having pain and to evaluate the possible factors associated. A consecutive sample of cancer patients admitted to an acute pain relief and palliative care unit during 8 months was surveyed. Most patients (147, 86.5%) were receiving opioids at admission. The mean age was 65.1 (SD 12.2) and 106 patients were males. Twenty-five patients presented with dysuria at admission (of which 22 were taking opioids, 14.9%). Eleven patients were inserted a bladder catheter at admission for urine monitoring and 18 patients had urinary incontinence. During admission, 31 patients presented dysuria (19…

AdultMalemedicine.medical_specialtyPalliative carePopulationPainUrinary incontinenceurologic and male genital diseasesSettore MED/42 - Igiene Generale E ApplicataDysuriaNeoplasmsInternal medicinePrevalenceHumansMedicineDysuriapatients with advanced cancer painPrevalence of opioid-related dysuriaSex DistributioneducationAgedPain Measurementeducation.field_of_studybusiness.industryPalliative CareCancerGeneral MedicineMiddle AgedOpioid-Related Disordersmedicine.diseasefemale genital diseases and pregnancy complicationsSurgeryAnalgesics OpioidOpioidConcomitantFemaletrial clinicomedicine.symptombusinessCancer painPrevalence of opioid-related dysuria; patients with advanced cancer pain; trial clinicomedicine.drug
researchProduct

Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit

2013

Abstract BACKGROUND: This survey was performed to draw information on pain prevalence, intensity, and management from a sample of patients who were admitted to an oncologic center where a palliative care unit (PCU) has been established for 13 years. METHODS: Cross-sectional survey in an oncological department performed 1 day per month for six consecutive months. RESULTS: Of the 385 patients, 69.1, 19.2, 8.6, and 3.1 % had no pain, mild, moderate, and severe pain, respectively. Inpatients and patients with a low Karnofsky score showed higher levels of pain intensity (p < 0.0005). One hundred twenty-eight patients with pain or receiving analgesics were analyzed for pain management index (PMI)…

AdultMalemedicine.medical_specialtyPalliative careSettore MED/06 - Oncologia MedicaCross-sectional studyPain medicineMEDLINEPainSettore MED/41 - AnestesiologiaOpioidSettore MED/42 - Igiene Generale E ApplicataYoung AdultNeoplasmsPrevalencemedicineHumansPain ManagementChemotherapyKarnofsky Performance StatusYoung adultAgedPain MeasurementAnalgesicsbusiness.industryNursing researchBreakthrough PainPalliative CareMiddle AgedCross-Sectional StudiesOncologyOpioidChemotherapy; Opioid; PainEmergency medicinePhysical therapyFemaleCancer painbusinessmedicine.drugSupportive Care in Cancer
researchProduct

Pattern and characteristics of advanced cancer patients admitted to hospices in Italy

2013

Abstract The aim of this multicenter study was to assess the pattern and the characteristics of advanced cancer patients admitted to hospices. A consecutive sample of patients admitted in a period of 6 months was taken into consideration. Two hundred thirty-six patients admitted to hospices were consecutively assessed. Ninety-six percent of patients were admitted in acute hospital in the previous 3 months, with a mean time spent in hospital of 34.5 days, and 47 % of patients had received chemotherapy the month before hospice admission. Thirty-four percent of patients for whom data were available had significant persistent pain, and 44 % of them presented episodes of breakthrough pain. Sixty…

AdultMalemedicine.medical_specialtyPalliative caredescriptive studyPain medicineSettore MED/42 - Igiene Generale E ApplicataFentanyladvanced cancer patientNeoplasmsOutcome Assessment Health CaremedicineHumansProspective StudiesIntensive care medicineProspective cohort studySurvival analysisAgedadvanced cancer patients; hospice; descriptive studyAged 80 and overTerminal CareMarital Statusbusiness.industryNursing researchPalliative CareHospicesLength of StayMiddle AgedSurvival AnalysisAnalgesics OpioidLogistic ModelsOncologyOpioidItalyhospiceEmergency medicineMarital statusFemalebusinessmedicine.drug
researchProduct

Assessing age and gender in studies of breakthrough pain medications

2014

AbstractObjective:The present review was performed to identify possible differences observed between adults and elderly patients and between males and females in randomized clinical trials of breakthrough pain (BTP).Methods:A systematic search of the existing literature from 1998 to September 2013 was performed. Randomized clinical trials reporting data on older patients were selected.Results:Sixteen comparative studies were selected. The age range of inclusion criteria patients was mainly between 18–80 or ≥18 years. In some cases this data was unreported. The mean age of patients was 48–64 years, but information regarding the number of elderly patients was present in three studies only. Ge…

AdultMalemedicine.medical_specialtyPediatricsBreakthrough PainSubgroup analysislaw.inventionAge and genderSex FactorsRandomized controlled trialOlder patientslawNeoplasmsmedicineHumansPsychiatryAdverse effectAgedRandomized Controlled Trials as Topicbusiness.industryBreakthrough PainAge FactorsGender distributionGeneral Medicinebreakthrough pain cancer painAnalgesics OpioidTreatment OutcomeFemaleCancer painbusinessCurrent Medical Research and Opinion
researchProduct

Nonmedical use of prescription drugs in the European Union

2016

Background Nonmedical prescription drug use (NMPDU) refers to the self-treatment of a medical condition using medication without a prescriber’s authorization as well as use to achieve euphoric states. This article reports data from a cross-national investigation of NMPDU in five European Countries, with the aim to understand the prevalence and characteristics of those engaging in NMPDU across the EU. Methods A parallel series of self-administered, cross-sectional, general population surveys were conducted in 2014. Data were collected using multi-stage quota sampling and then weighted using General Exponential Model. A total of 22,070 non-institutionalized participants, aged 12 to 49 years, …

AdultMalemedicine.medical_specialtyPrescription drugPrescription DrugsCross-sectional studySubstance-Related Disordersmedicine.medical_treatmentDenmarkPopulationPharmacyThinking03 medical and health sciencesYoung Adult0302 clinical medicineRisk FactorsGermanymedicinePrevalencemedia_common.cataloged_instanceHypnotics and SedativesHumans030212 general & internal medicineEuropean UnionEuropean unionMedical prescriptionPsychiatryeducationPrescription Drug MisuseReproductive healthmedia_commonSwedeneducation.field_of_studybusiness.industryUnited KingdomStimulantAnalgesics OpioidEuropePsychiatry and Mental healthCross-Sectional StudiesSpainCentral Nervous System StimulantsFemalebusiness030217 neurology & neurosurgeryResearch ArticleBMC Psychiatry
researchProduct

Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey.

2008

The aim of this national cross-sectional survey was to draw information on pain prevalence and intensity from a large sample of patients who were admitted to oncologic centres for different reasons and to evaluate the pain treatment and possible influencing factors.A total of 2,655 patients completed the study. Nine hundred and one patients (34%) reported pain.Higher pain levels were observed in inpatients, in the presence of bone metastases, and with low levels of Eastern Cooperative Oncology Group status. The number of patients receiving strong opioids increased with the highest levels of pain. However, a significant part of patients with moderate-severe pain were not receiving appropriat…

AdultMalemedicine.medical_specialtySettore MED/06 - Oncologia MedicaCross-sectional studyPain medicineMEDLINEPainSeverity of Illness IndexNeoplasmsOncology Service HospitalEpidemiologySeverity of illnessmedicinePrevalenceHumansAgedAged 80 and overPrimary Health Carebusiness.industryCancer painEpidemiologyOpioidsNursing researchPhysicians FamilyMiddle AgedLarge sampleAnalgesics OpioidCross-Sectional StudiesOncologyItalyFamily medicineHealth Care SurveysPhysical therapyFemaleCancer painbusinessSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
researchProduct

Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain

2015

Purpose: The aim of the present study was to assess the long-term tolerability and efficacy of intranasal fentanyl (INFS) in opioid-tolerant patients with breakthrough cancer pain (BTP).Patients and methods: A 6 months, observational, prospective, cohort study design was employed to follow advanced cancer patients with BTP receiving INFS under routine clinical practice. Eligible adult cancer patients suffering from BTP had been prescribed INFS at effective doses. Data were collected at T0 and at month intervals for six months. The principal outcomes were the evaluation of possible serious adverse effects with prolonged use of INFS, the efficacy of BTP treatment with INFS, the quality of sle…

AdultMalemedicine.medical_specialtySettore MED/42 - Igiene Generale E ApplicataFentanylCohort StudiesPatient satisfactionNeoplasmsInternal medicineparasitic diseasesHumansPain ManagementMedicineProspective StudiesCancer painAdverse effectProspective cohort studyAdministration IntranasalAgedPain Measurementbusiness.industryBreakthrough PainMiddle AgedTolerabilityDiscontinuationAnalgesics OpioidFentanylBreakthrough pain; Cancer pain; Intranasal fentanyl; Tolerability; OncologyOncologyTolerabilityPatient SatisfactionAnesthesiaIntranasal fentanylFemaleSleepbusinessCancer painmedicine.drugCohort studySupportive Care in Cancer
researchProduct